Recruiting Rheumatoid Arthritis Studies in Boardman
About Rheumatoid Arthritis Clinical Trials in Boardman
Rheumatoid arthritis (RA) is a chronic autoimmune disease affecting approximately 1.3 million Americans, where the immune system mistakenly attacks joint linings, causing painful swelling, bone erosion, and joint deformity. Early diagnosis and treatment are critical to prevent irreversible damage. Current standard treatments include methotrexate and other DMARDs, TNF inhibitors (etanercept, infliximab), IL-6 inhibitors (tocilizumab), T-cell costimulation modulators (abatacept), and JAK inhibitors (tofacitinib, baricitinib). Clinical trials are now exploring next-generation targeted therapies, dual-pathway inhibitors, and treatment strategies aimed at achieving sustained remission rather than just symptom control. Patients with inadequate response to conventional DMARDs or biologics are commonly eligible for enrollment.
There are currently 1 rheumatoid arthritis clinical trials recruiting participants in Boardman, OH. These studies are seeking a combined 149 participants. Research is being sponsored by Sitryx Therapeutics Ltd. Clinical trial participation is free and participants receive study-related medical care at no cost.
Rheumatoid Arthritis Clinical Trials in Boardman — FAQ
Are there rheumatoid arthritis clinical trials in Boardman?
Yes, there are 1 rheumatoid arthritis clinical trials currently recruiting in Boardman, OH. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Boardman?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Boardman research site will contact you about next steps.
Are clinical trials in Boardman free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Boardman studies also compensate for your time and travel.
What rheumatoid arthritis treatments are being tested?
The 1 active trials in Boardman are testing new therapies including novel drugs, biologics, and treatment approaches for rheumatoid arthritis.
Data updated July 13, 2026 from ClinicalTrials.gov